Qiagen and Agilent both had strong stock gains during the past week, leading the BioCommerce Week Index of multi-platform molecular biology tool firms. Qiagen shares rose 10 percent, though the reason for the upward movement is not readily apparent. Agilent's shares climbed 9.78 percent, due largely to a report in the Wall Street Journal that the firm's semiconductor business could be sold as early as late this week for as much as $2.5 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.